JP2016508506A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508506A5
JP2016508506A5 JP2015556454A JP2015556454A JP2016508506A5 JP 2016508506 A5 JP2016508506 A5 JP 2016508506A5 JP 2015556454 A JP2015556454 A JP 2015556454A JP 2015556454 A JP2015556454 A JP 2015556454A JP 2016508506 A5 JP2016508506 A5 JP 2016508506A5
Authority
JP
Japan
Prior art keywords
group
alkyl
ring
groups
ring member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015556454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508506A (ja
JP6314335B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/051878 external-priority patent/WO2014122067A1/en
Publication of JP2016508506A publication Critical patent/JP2016508506A/ja
Publication of JP2016508506A5 publication Critical patent/JP2016508506A5/ja
Application granted granted Critical
Publication of JP6314335B2 publication Critical patent/JP6314335B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015556454A 2013-02-06 2014-01-31 新しいインダニルオキシジヒドロベンゾフラニル酢酸 Expired - Fee Related JP6314335B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13154261 2013-02-06
EP13154261.5 2013-02-06
PCT/EP2014/051878 WO2014122067A1 (en) 2013-02-06 2014-01-31 New indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2016508506A JP2016508506A (ja) 2016-03-22
JP2016508506A5 true JP2016508506A5 (enExample) 2017-03-09
JP6314335B2 JP6314335B2 (ja) 2018-04-25

Family

ID=47681765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015556454A Expired - Fee Related JP6314335B2 (ja) 2013-02-06 2014-01-31 新しいインダニルオキシジヒドロベンゾフラニル酢酸

Country Status (7)

Country Link
US (1) US8927531B2 (enExample)
EP (1) EP2953681B1 (enExample)
JP (1) JP6314335B2 (enExample)
AR (1) AR095163A1 (enExample)
TW (1) TW201518284A (enExample)
UY (1) UY35312A (enExample)
WO (1) WO2014122067A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3068788A1 (en) 2013-11-14 2016-09-21 Cadila Healthcare Limited Novel heterocyclic compounds
CN105566263A (zh) * 2016-01-27 2016-05-11 中国药科大学 一类新型含氮杂环衍生物、其制备方法及其作为药物的用途
JOP20190060A1 (ar) * 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
JP7461104B2 (ja) * 2017-11-29 2024-04-03 中外製薬株式会社 Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
CR20200347A (es) 2018-02-13 2020-09-23 Gilead Sciences Inc Inhibidores pd-1/pd-l1
TWI712412B (zh) 2018-04-19 2020-12-11 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
SG11202012425QA (en) 2018-07-13 2021-01-28 Gilead Sciences Inc Pd-1/pd-l1 inhibitors
WO2020086556A1 (en) 2018-10-24 2020-04-30 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제
HRP20241159T1 (hr) 2020-02-07 2024-12-06 Gasherbrum Bio, Inc. Heterociklički agonisti za glp-1
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
CN116368140A (zh) 2020-09-10 2023-06-30 加舒布鲁姆生物公司 杂环glp-1激动剂
CN120957993A (zh) 2023-02-16 2025-11-14 加舒布鲁姆生物公司 杂环glp-1激动剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
CA2505322A1 (en) 2002-11-08 2004-05-21 Takeda Pharmaceutical Company Limited Receptor function regulator
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
EP1924546A1 (en) 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
MX2008011615A (es) * 2006-03-14 2008-09-22 Amgen Inc Derivados de acidos carboxilicos biciclicos utiles para tratar trastornos metabolicos.
RS53230B (sr) 2006-06-27 2014-08-29 Takeda Pharmaceutical Company Limited Kondenzovana ciklična jedinjenja kao modulatori gpr40 receptora
KR20110027657A (ko) 2008-06-25 2011-03-16 다이이찌 산쿄 가부시키가이샤 카르복실산 화합물
WO2010143733A1 (en) * 2009-06-09 2010-12-16 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
DK2646425T3 (en) * 2010-12-01 2015-08-24 Boehringer Ingelheim Int Indanyloxydihydrobenzofuranylacetic acids useful for the treatment of metabolic syndrome.
US8809376B2 (en) * 2012-04-30 2014-08-19 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids

Similar Documents

Publication Publication Date Title
JP2016508506A5 (enExample)
JP2018535963A5 (enExample)
JP2011523412A5 (enExample)
ECSP22008098A (es) Compuestos agonistas de gipr
EP4691555A3 (en) Incretin analogs and uses thereof
JP2014511891A5 (enExample)
JP2016515561A5 (enExample)
JP2016513130A5 (enExample)
JP2019524883A5 (enExample)
JP2013519675A5 (enExample)
JP2013542261A5 (enExample)
MX2015001500A (es) Compuestos antidiabeticos triciclicos.
JP2018536648A5 (enExample)
JP2007538024A5 (enExample)
JP2010523476A5 (enExample)
JP2016500661A5 (enExample)
JP2016503797A5 (enExample)
MX2016015182A (es) Compuestos triciclicos antidiabeticos.
CL2021000528A1 (es) Compuestos de 2,6-diaminopiridina
JP2016510326A5 (enExample)
RU2015147447A (ru) Производные доластатина 10 и ауристатинов
JP2020517619A5 (enExample)
JP2015516427A5 (enExample)
JP2019516739A5 (enExample)
JP2016504400A5 (enExample)